GW Pharma (NASDAQ:GWPH) is set to release its Q1 2020 earnings on May 11th.
The company has had further positive developments so far this year. The stock price had been held back more by technical factors and outside developments rather than by core prospects for the company.
The provision of medication for epilepsy patients should not be directly affected by COVID-19. However the company's overseas expansion may have been slowed down. It is possible that testing and development work in both the USA and Europe may have been delayed by the restrictions.
More